Department of Materials Science and Engineering, Inha University, Incheon, Korea.
Anticancer Drugs. 2011 Nov;22(10):971-7. doi: 10.1097/CAD.0b013e32834b859c.
In-vivo animal tests were performed to investigate the feasibility of photothermal therapy based on porous silicon nanoparticles (PSiNPs) in combination with a near-infrared (NIR) laser. The in-vivo animal test results showed that the murine colon carcinoma (CT-26) tumors were completely resorbed with minimal damage to surrounding healthy tissue within 5 days after PSiNPs and NIR laser treatments. In contrast, tumors in the groups treated only with PSiNPs or NIR and a control group continued to grow until the mice died. All of the mice treated with both PSiNPs and NIR remained healthy and free of tumors even 90 days after the treatment. In-vivo fluorescence imaging and the urine and feces tests revealed that PSiNPs injected intratumorally into mice were cleared mainly through the urine. The in-vivo animal test results suggest that thermotherapy based on porous silicon in combination with NIR laser irradiation can efficiently destroy cancer cells selectively without damaging the surrounding healthy cells.
进行了体内动物试验,以研究基于多孔硅纳米粒子(PSiNPs)结合近红外(NIR)激光的光热疗法的可行性。体内动物试验结果表明,PSiNPs 和 NIR 激光治疗后 5 天内,鼠结直肠癌(CT-26)肿瘤完全吸收,周围健康组织损伤最小。相比之下,仅用 PSiNPs、NIR 或对照组治疗的肿瘤继续生长,直到小鼠死亡。所有接受 PSiNPs 和 NIR 联合治疗的小鼠在治疗后 90 天内仍然健康,没有肿瘤。体内荧光成像以及尿液和粪便检测表明,肿瘤内注射的 PSiNPs 主要通过尿液清除。体内动物试验结果表明,基于多孔硅的热疗结合 NIR 激光照射可以有效地选择性地破坏癌细胞,而不会损伤周围的健康细胞。